Brazil suspends Bharat Biotech s Covaxin clinical trials thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.
1085
Hyderabad, July 24
Brazil has suspended the clinical studies of Bharat Biotech’s Covid-19 vaccine, Covaxin following termination of the company’s agreement with its partner there, the South American Country’s health regulator said.
Bharat Biotech on Friday announced cancellation of the MoU it signed with Precisa Medicamentos and Envixia Pharmaceuticals LL.C for its COVID-19 vaccine Covaxin for the Brazilian market.
The termination of the pact comes after the deal with the Brazilian government for supply of 20 million doses of the vaccine landed in controversy and attracted investigation by authorities in that country.
“In the Coordination of Clinical Research at Anvisa (Copec/GGMED) determined this Friday (23/7) the precautionary suspension of clinical studies of the Covaxin vaccine in Brazil
Brazil suspends Covaxin clinical trials after Bharat Biotech cancels contracts with its partner
The termination of the pact comes after the deal with the Brazilian government for supply of 20 million doses of the vaccine landed in controversy and attracted investigation by authorities.
Share Via Email
| A+A A- By PTI
HYDERABAD: Brazil has suspended the clinical studies of Bharat Biotech s COVID-19 vaccine, Covaxin following termination of the company s agreement with its partner there, the South American Country s health regulator said.
Bharat Biotech on Friday announced cancellation of the MoU it signed with Precisa Medicamentos and Envixia Pharmaceuticals LL.C for its COVID-19 vaccine Covaxin for the Brazilian market.
Brazil suspends clinical trials of Bharat Biotech s Covaxin indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
Brazil has suspended the clinical studies of Bharat Biotech s COVID-19 vaccine, Covaxin following termination of the company s agreement with its partner there, the South American Country s health regulator said.
Bharat Biotech on Friday announced cancellation of the MoU it signed with Precisa Medicamentos and Envixia Pharmaceuticals LL.C for its COVID-19 vaccine Covaxin for the Brazilian market. The termination of the pact comes after the deal with the Brazilian government for supply of 20 million doses of the vaccine landed in controversy and attracted investigation by authorities in that country. In The Coordination of Clinical Research at Anvisa (Copec/GGMED) determined this Friday (23/7) the precautionary suspension of clinical studies of the Covaxin vaccine in Brazil